{"id":"NCT00347932","sponsor":"Bausch & Lomb Incorporated","briefTitle":"A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.","officialTitle":"A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2006-07-04","resultsPosted":"2009-08-13","lastUpdate":"2015-03-24"},"enrollment":957,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Bacterial Conjunctivitis"],"interventions":[{"type":"DRUG","name":"ISV-403","otherNames":["besifloxacin","Besivance","BOL-303224"]},{"type":"DRUG","name":"Vehicle","otherNames":[]}],"arms":[{"label":"ISV-403","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.","primaryOutcome":{"measure":"Clinical Resolution of Baseline Bacterial Conjunctivitis","timeFrame":"Day 5 +/- 1 day","effectByArm":[{"arm":"ISV-403","deltaMin":90,"sd":null},{"arm":"Vehicle","deltaMin":63,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["32841261","20629472","19323612"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":442},"commonTop":[]}}